A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer

Journal of Urology

Volumn 155, Issue 2, 1996, Pages 495-500

  Freiha, Fuad ^b   Reese, Jeffrey ^b   Torti, Frank M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

bladder neoplasms; carcinoma, transitional cell; chemotherapy, adjuvant; drug therapy

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0030049159     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66430-9     Document Type: Article

References (19)

1. Wishnow, K. I., Levinson, A. K., Johnson, D. E., Tenney, D. M., Grignon, D. J., Ro, J. Y., Ayala, A. J., Logothetis, C. J., Swanson, D. A., Babaian, R. J. and vonEschenbach, A. C.: Stage B (P2/3A/No) transitional cell carcinoma of bladder highly curable by radical cystectomy. Urology, 39: 12, 1992.
2. Stöckle, M., Alken, P., Engelmann, U., Jacobi, G. H., Riedmiller, H. and Hohenfellner, R.: Radikale Zystecktomie - oft zu spat? Akt. Urol., 17: 234, 1986.
3. Lerner, S. P., Skinner, D. G., Lieskovsky, G., Boyd, S. D., Groshen, S. L., Ziogas, A., Skinner, E., Nichols, P. and Hopwood, B.: The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J. Urol., 149: 758, 1993.
4. LaPlante, M. and Brice, M., III: The upper limits of hopeful application of radical cystectomy for vesical carcinoma: does nodal metastasis always indicate incurability? J. Urol., 109: 261, 1973.
5. Dretler, S. P., Ragsdale, B. D. and Leadbetter, W. F.: The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J. Urol., 109: 414, 1973.
6. Smith, J. A., Jr. and Whitmore, W. F., Jr.: Regional lymph node metastasis from bladder cancer. J. Urol., 126: 591, 1981.
7. Skinner, D. G., Tift, J. P. and Kaufman, J. J.: High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. J. Urol., 127: 671, 1982.
8. Harker, W. G., Meyers, F. J., Freiha, F. S., Palmer, J. M., Shortliffe, L. D., Hannigan, J. F., McWhirter, K. M. and Torti, F. M.: Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J. Clin. Oncol., 3: 1463, 1985.
9. Miller, R. S., Freiha, F. S., Reese, J. H., Ozen, H. and Torti, F. M.: Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. J. Urol., 150: 65, 1993.
10. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
11. Dreicer, R., Kollmorgen, T. A., Smith, R. F. and Williams, R. D.: Neoadjuvant cisplatin, methotrexate and vinblastine for muscle-invasive bladder cancer: long-term followup. J. Urol., 150: 849, 1993.
12. Fair, W. R., Scher, H., Herr, H., Morse, M., Sogani, P., Bosh, G., Dershaw, D., Reuter, V., Curley, T. and Whitmore, W. F., Jr.: Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience. Sem. Urol., 8: 190, 1990.
13. Fossa, S. D., Harland, S. J., Kaye, S. B., Raghavan, D., Russell, J. M., Parmar, M. K. B., Uscinska, B. M., Wood, R. and the MRC Subgroup in Advanced Bladder Cancer: Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma - response rate and pitfalls. Brit. J. Urol., 70: 161, 1992.
14. Frassoldati, A., Federico, M., Barbieri, F., Brausi, M., Pollastri, C., Berri, G., Castagnetti, G., Palladini, P. P. and Silingardi, V.: Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer. Med. Oncol. Tumor Pharmacother., 8: 99, 1991.
15. Paz-Ares, L., Lianes, P., Díaz-Puente, M., Rivera, F., Passas, J., Costas, P., Mendiola, C. and Cortés-Funes, H.: CMV front-line chemotherapy in transitional bladder carcinoma. Ann. Oncol., 4: 147, 1993.
16. Kaufman, D. S., Shipley, W. U., Griffin, P. P., Heney, N. M., Althausen, A. F. and Efird, J. T.: Selective bladder preservation by combination treatment of invasive bladder cancer. New Engl. J. Med., 329: 1377, 1993.
17. Logothetis, C. J., Johnson, D. E., Chong, C., Dexeus, F. H., Ogden, S., von Eschenbach, A. and Ayala, A.: Adjuvant chemotherapy of bladder cancer: a preliminary report. J. Urol., 139: 1207, 1988.
18. Skinner, D. G., Daniels, J. R., Russell, C. A., Lieskovsky, G., Boyd, S. D., Nichols, P., Kern, W., Sakamoto, J., Krailo, M. and Groshen, S.: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J. Urol., 145: 459, 1991.
19. Stöckle, M., Meyenburg, W., Wellek, S., Voges, G., Gertenbach, U., Thüroff, J. W., Huber, Ch. and Hohenfellner, R.: Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J. Urol., 148: 302, 1992.